These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19132233)

  • 1. Effect of oral antiplatelet agents on major bleeding in users of coumarins.
    Schalekamp T; Klungel OH; Souverein PC; de Boer A
    Thromb Haemost; 2008 Dec; 100(6):1076-83. PubMed ID: 19132233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bleeding risks with combination of oral anticoagulation plus antiplatelet therapy: is clopidogrel any safer than aspirin when combined with warfarin?
    Tay KH; Lane DA; Lip GY
    Thromb Haemost; 2008 Dec; 100(6):955-7. PubMed ID: 19132214
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins.
    Schalekamp T; Klungel OH; Souverein PC; de Boer A
    Arch Intern Med; 2008 Jan; 168(2):180-5. PubMed ID: 18227365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of bleeding after hospitalization for a serious coronary event: a retrospective cohort study with nested case-control analyses.
    González-Pérez A; Sáez ME; Johansson S; Himmelmann A; García Rodríguez LA
    BMC Cardiovasc Disord; 2016 Aug; 16(1):164. PubMed ID: 27577589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis.
    Melkonian M; Jarzebowski W; Pautas E; Siguret V; Belmin J; Lafuente-Lafuente C
    J Thromb Haemost; 2017 Jul; 15(7):1500-1510. PubMed ID: 28393461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants.
    Penning-van Beest FJ; Koerselman J; Herings RM
    J Thromb Haemost; 2008 Feb; 6(2):284-90. PubMed ID: 18031295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
    Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
    Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Main comedications associated with major bleeding during anticoagulant therapy with coumarins.
    Penning-van Beest F; Erkens J; Petersen KU; Koelz HR; Herings R
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):439-44. PubMed ID: 15947920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications.
    García Rodríguez LA; Lin KJ; Hernández-Díaz S; Johansson S
    Circulation; 2011 Mar; 123(10):1108-15. PubMed ID: 21357821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet drugs and risk of subarachnoid hemorrhage: a population-based case-control study.
    Schmidt M; Johansen MB; Lash TL; Christiansen CF; Christensen S; Sørensen HT
    J Thromb Haemost; 2010 Jul; 8(7):1468-74. PubMed ID: 20345728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral anticoagulation with vitamin K antagonists].
    Alberio L
    Ther Umsch; 2003 Jan; 60(1):5-9. PubMed ID: 12638470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Antithrombotic Drug Use With Subdural Hematoma Risk.
    Gaist D; García Rodríguez LA; Hellfritzsch M; Poulsen FR; Halle B; Hallas J; Pottegård A
    JAMA; 2017 Feb; 317(8):836-846. PubMed ID: 28245322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interactions with phenprocoumon and the risk of serious haemorrhage: a nested case-control study in a large population-based German database.
    Jobski K; Behr S; Garbe E
    Eur J Clin Pharmacol; 2011 Sep; 67(9):941-51. PubMed ID: 21452031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.
    Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM
    Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction.
    Buresly K; Eisenberg MJ; Zhang X; Pilote L
    Arch Intern Med; 2005 Apr; 165(7):784-9. PubMed ID: 15824298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
    Taha AS; Angerson WJ; Knill-Jones RP; Blatchford O
    Aliment Pharmacol Ther; 2006 Feb; 23(4):489-95. PubMed ID: 16441469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study.
    Christiansen CB; Pallisgaard J; Gerds TA; Olesen JB; Jørgensen ME; Numé AK; Carlson N; Kristensen SL; Gislason G; Torp-Pedersen C
    BMC Neurol; 2015 Nov; 15():225. PubMed ID: 26525411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
    Jones L; Griffin S; Palmer S; Main C; Orton V; Sculpher M; Sudlow C; Henderson R; Hawkins N; Riemsma R
    Health Technol Assess; 2004 Oct; 8(38):iii-iv, 1-196. PubMed ID: 15461876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
    DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
    Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.